Neomycin Sulfate; Nystatin; Thiostrepton; Triamcinolone Acetonide

11 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

910.0%

Death Rate

Active Ingredients

Neomycin Sulfate; Nystatin; Thiostrepton; Triamcinolone Acetonide

Administration Routes

TopicalUnknownAuricular (Otic)

Species Affected

Dog 5

Unknown 3

Cat 3

Most Affected Breeds

Unknown 3

Newfoundland 2

Domestic Shorthair 2

Terrier - Yorkshire 1

Bulldog 1

Siamese 1

Spaniel (unspecified) 1

Most Reported Reactions

Tubes, Leaking 2

Deafness 2

Pruritus 2

Tubes, Abnormal 1

Deafness NOS 1

Internal ear disorder 1

Crust 1

Pinnae disorder 1

Periorbital oedema 1

Agitation 1

Vocalisation 1

Diarrhoea 1

Outcome Breakdown

Ongoing

3 (37.5%)

Outcome Unknown

2 (25.0%)

Recovered/Normal

2 (25.0%)

Euthanized

1 (12.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.